HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Science-Backed Products, Better User Experience Sell Self-Care – Bayer Consumer Research Chief

Executive Summary

Self-care within next decade should help consumers prevent common ailments, says Bayer consumer health research executive Dave Evendon-Challis. Bayer aims to steer consumers into effective self-care using credible science behind its products and improving the user experience.

You may also be interested in...

Bayer Leads Push For Self-Care In India As Local Business Launches

Bayer has launched a dedicated Consumer Health business in India to market products in key OTC categories. The company is also working to bring different stakeholders together through the creation of a new organization dedicated to promoting self-care in the South Asian country.

Post-COVID Consumers Want Digitally Enabled, Personalized And Continuous Self-Care

Digital apps, wearables and home diagnostic tests - as well as dietary supplements - offer today's consumers ways of personalizing and embedding self-care into daily life, argued panelists at IQVIA Consumer Health's latest webinar.

OTC Decisions August-October: More Providers Enter Diclofenac, Lansoprazole, Loratadine Markets

CDER’s August-September OTC application approvals are highlighted by Arbor Pharmaceuticals’ ivermectin 0.5% lice treatment. Orange Book changes also include four firms’ approvals for labeling to market generic equivalents of Voltaren Arthritis Relief launched as an OTC switch since earlier in 2020.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts